Clinical Trials
5 trialsNCT07137598 2026-06-01
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Hoffmann-La Roche
Phase 2 Recruiting
NCT06712628 2026-02-17
UP-RISING
AbbVie
Recruiting
NCT03270982 2025-12-23
Comprehensive Segmental Revision System
Zimmer Biomet
Active not recruiting
NCT05413044 2025-12-08
A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register
Bristol-Myers Squibb
Completed
NCT05421442 2025-12-08
DANBIO
Bristol-Myers Squibb
Completed